 |
|
Summary of Korean Asthma Guideline
Chin Kook Rhee, Ji‑Yong Moon, Hyonsoo Joo, Ji Ye Jung, Jung-Kyu Lee, Kyung Hoon Min, Hyeon-Kyoung Koo, Seong Yong Lim, Hyoung Kyu Yoon, Sang Yeub Lee,
Tuberc Respir Dis. 2023;86(3):158-165. Published online 2023 May 30 DOI: https://doi.org/10.4046/trd.2023.0052
|
|
Citations to this article as recorded by
 A Retrospective Study Evaluating Asthma Control in Patients on Fluticasone Propionate/Salmeterol Proactive Regular Dosing with a History of Uncontrolled Asthma
Ahmad Izuanuddin Ismail, Irfhan Ali Hyder Ali, Chee Kuan Wong, Andrea Yu-Lin Ban, Fatimah MZ Zahrah, Li Khen Lem, Zamzurina Abu Bakar, Arvindran Alaga, Azza Omar, Azlina Samsudin, Siew Li Lai, Alap Gandhi
Pulmonary Therapy.2025; 11(1): 25. CrossRef Exacerbation rates in Japanese patients with obstructive lung disease: A subanalysis of the prospective, observational NOVELTY study
Tomotaka Kawayama, Kenichi Takahashi, Toshikazu Ikeda, Kenya Fukui, Naoyuki Makita, Naoki Tashiro, Junpei Saito, Toshihiro Shirai, Hiromasa Inoue
Allergology International.2024; 73(1): 71. CrossRef The pharmacological management of asthma in adults: 2023 update
Maria Gabriella Matera, Barbara Rinaldi, Rosa Annibale, Vito De Novellis, Mario Cazzola
Expert Opinion on Pharmacotherapy.2024; 25(4): 383. CrossRef The Wiser Strategy of Using Beta-Agonists in Asthma: Mechanisms and Rationales
Dong In Suh, Sebastian L. Johnston
Allergy, Asthma & Immunology Research.2024; 16(3): 217. CrossRef Inhaled Corticosteroids and the Risk of Nontuberculous Mycobacterial Infection in Chronic Airway Disease: A Nationwide Population-Based Study
Eun Chong Yoon, Hyewon Lee, Hee-Young Yoon
Tuberculosis and Respiratory Diseases.2024; 87(4): 473. CrossRef
|